netFormulary NHS
Southampton Joint Formulary
 Formulary Chapter 6: Endocrine system - Full Section

06.01 Drugs used in diabetes
06.01.01 Insulins Short-acting insulins Intermediate- and long-acting insulins
Biphasic insulins Hypodermic equipment
06.01.02 Antidiabetic drugs Sulfonylureas Biguanides Other antidiabetic drugs
Alpha glucosidase inhibitors
DPP-4 inhibitors ('gliptins)
GLP-1 agonists/analogues
SGLT-2 inhibitors ('gliflozins)
06.01.03 Diabetic ketoacidosis
06.01.04 Treatment of hypoglycaemia
Chronic hypoglycaemia
06.01.05 Treatment of diabetic nephropathy and neuropathy
06.01.06 Diagnostic and monitoring agents for diabetes mellitus
Blood glucose monitoring
Oral glucose tolerance test
06.02 Thyroid and Antithyroid drugs
06.02.01 Thyroid hormones
06.02.02 Antithyroid drugs
06.03 Corticosteroids
06.03.01 Replacement therapy
06.03.02 Glucocorticoid therapy
06.04 Sex hormones
06.04.01 Female sex hormones and their modulators Oestrogens and HRT
Raloxifene Progestogens
06.04.02 Male sex hormones and antagonists
06.04.03 Anabolic steroids
06.05 Hypothalamic and pituitary hormones and anti-oestrogens
06.05.01 Hypothalamic and anterior pituitary hormones and anti-oestrogens
Anterior pituitary hormones
Hypothalmic hormones
06.05.02 Posterior pituitary hormones and antagonists
Posterior pituitary hormones
Antidiuretic hormone antagonists
06.06 Drugs affecting bone metabolism
06.06.01 Calcitonin and parathyroid hormone
06.06.02 Bisphosphonates and other drugs affecting bone metabolism
06.07 Other endocrine drugs
06.07.01 Bromocriptine and other dopaminergic drugs
06.07.02 Drugs affecting gonadotrophins
Gonadorelin analogues
06.07.03 Metyrapone
06.07.04 Somatomedins